Q4 2024 Inspire Medical Systems Inc Earnings Call Transcript
Key Points
- Inspire Medical Systems Inc (INSP) achieved its first full year of profitability in 2024, with a net income of $53.5 million compared to a net loss in 2023.
- The company reported a 25% increase in revenue for Q4 2024 compared to the same period in 2023, reaching $239.7 million.
- Inspire Medical Systems Inc (INSP) received FDA approval for the Inspire V neurostimulator, which simplifies the implantation process and reduces production complexity and cost.
- The company expanded its market presence by adding 72 new US centers and 12 new US sales territories in Q4 2024.
- Inspire Medical Systems Inc (INSP) has a strong cash position with $517 million in cash and investments as of December 31, 2024, allowing for continued investment in growth strategies.
- The company received a civil investigative demand from the Department of Justice regarding its marketing, promotion, and reimbursement practices.
- Despite profitability, Inspire Medical Systems Inc (INSP) does not expect to be profitable in Q1 2025 due to revenue seasonality.
- The full launch of the Inspire V neurostimulator is contingent on building sufficient inventory, which may delay its widespread availability.
- Operating expenses increased by 11% in Q4 2024 compared to the same period in 2023, primarily due to sales organization expansion and increased corporate costs.
- The company faces potential challenges with the reimplementation of DISE requirements by UnitedHealthcare, which could impact patient qualification processes.
Good afternoon. My name is Dilem, and I'll be your conference operator today.
At this time, I would like to welcome everyone to the Inspire Medical Systems fourth-quarter and full year 2024 conference call.
(Operator Instructions)
I'll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Thank you, Dilem, and thank you all for participating in today's call.
Joining me are Tim Herbert, Chairman and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer.
Earlier today, we released financial results for the 3 and 12 months ended December 31, 2024. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including without limitation, those relating to our operations, financial results,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
